D. Mandarino

Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults

D. Kowalski, A. Groll, T. Yamazaki, 2016, Clinical pharmacology in drug development.

, Male Subjects Virus NS 3 / 4 Protease Inhibitor , in Healthy Steady-State Faldaprevir , a Hepatitis C Mass Balance and Metabolite Profiling of

R. George, C. Yong, B. Latli, 2014 .

Mass Balance and Metabolite Profiling of Steady-State Faldaprevir, a Hepatitis C Virus NS3/4 Protease Inhibitor, in Healthy Male Subjects

Yongmei Li, C. Yong, R. St George, 2014, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men.

A. Wheeler, P. Winkler, I. Prakash, 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Placebo-Controlled, Double-Blind, First-In-Human, Ascending Single Dose and Multiple Dose, Healthy Subject Study Of Intravenous-Administered SelG1, a Humanized Anti-P-Selectin Antibody In Development For Sickle Cell Disease

R. Alvarez, R. Rother, S. Rollins, 2013 .

Mass Balance, Metabolite Profile, and In Vitro-In Vivo Comparison of Clearance Pathways of Deleobuvir, a Hepatitis C Virus Polymerase Inhibitor

R. Sane, D. Ramsden, B. Latli, 2014, Antimicrobial Agents and Chemotherapy.

Healthy volunteers in first‐in‐human oncology drug development for small molecules

N. Steeghs, L. Vidal, Lesley Reeve, 2021, British journal of clinical pharmacology.

Mass Balance and Metabolite Profiling of Steady-State Faldaprevir, a Hepatitis C Virus NS3/4 Protease Inhibitor, in Healthy Male Subjects

R. George, C. Yong, B. Latli, 2014 .